Categories AlphaGraphs, Earnings, Finance

A visual dashboard of Charles Schwab (SCHW) Q2 2020 earnings results

Charles Schwab (NYSE: SCHW) reported a year-over-year drop in earnings and revenue for the second quarter of 2020. Adjusted EPS of $0.54 and GAAP EPS of $0.48, declined 21% and 19%, respectively. Revenue dropped 9% to $2.45 billion in the second quarter. Shares of Charles Schwab were down about 3% in the pre-market trading session.

Check this space for the transcript of Charles Schwab Q2 2020 earnings conference call

Charles Schwab (SCHW) Q2 2020 Earnings AlphaGraph

“Throughout the second quarter, the COVID-19 pandemic and its effects continued to dominate the macroeconomic environment, presenting myriad challenges for our clients and Schwab alike,” said CEO Walt Bettinger.

Most Popular

Biogen (BIIB) stock research summary | Q3 2021

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of

Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings

Goldman Sachs (GS) stock research summary | Q3 2021

Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key

Add Comment
Viewing Highlight